The current opioid epidemic has affected nearly
every aspect of American society.
Opioids are entering our homes in a conventional manner and harming our loved ones in unconventional ways. In 2015, a staggering 52,404 deaths by overdose were reported, making drug overdose the leading cause of accidental death in the United States.
We are devoted to making a positive change in the opioid crisis by using our 20 plus years of subject matter expertise to support and provide prevention, treatment, and recovery strategies and services aimed at reducing and eliminating opioid use disorders and its effects on our nation.
Our team of public health experts—seasoned physicians, pharmacists, public health specialists, and educators—has developed a comprehensive approach to minimize the impact of opioid use disorders in our communities.
Our subject matter experts have developed innovative prevention and treatment models, and strategies for addressing barriers to preventing and treating substance use disorders.
Bizzell provides comprehensive and innovative services to mitigate the effects of Overdose Use Disorder, educate the public and prevent overdose.
Our subject matter experts effectively collaborate with treatment programs, professional organizations, governmental entities, and other stakeholders to provide address the opioid epidemic using a variety of techniques.
Our services include:
- Assessment of program to determine compliance with best practice guidelines and applicable regulations.
- Customize consultation to enhance clinical performance, program outcomes and workforce development.
- Engaging provider communities to develop and adopt useful clinical tools and guidelines that affect diagnosis and treatment.
- Providing ongoing education on substance use disorders and treatment to law enforcement communities, patient advocates, practitioners, and other relevant stakeholders.
- Providing online and in-person training that addresses topics such as performance improvement, FDA approved medications, infectious disease, and cultural competence.
Opioid Technical Assistance and Provider Education
Bizzell supports SAMHSA in the administration of OTP–Q. The focus of this project is to help opioid treatment programs (OTPs) and state agencies identify any changes needed to meet accreditation standards and give them the resources to make those changes. Bizzell provides technical assistance to more than 1,600 opioid treatment programs, provider groups, and state systems responsible for developing policy and programming for medically assisted treatment.
The project is also responsible for providing medical education to clinical professionals, including medical directors, nurses, physician assistants, and clinical supervisors working with individuals addicted to opiates. The Opioid Treatment Program–Quality (OTP–Q) contract is funded through the SAMHSA’s Division of Pharmacologic Therapies.
Prescriber Education and Technical Assistance
Bizzell, as a teammate of Boston University, assists the FDA Risk Evaluation and Mitigation Strategies (REMS) grant by providing logistics for trainings throughout the United States, for which attendees can earn professional development hours. The FDA has mandated manufacturers of extended-release/long-acting (ER/ LA) opioid analgesics to make available comprehensive prescriber education in the safe use of these medications, based on the FDA curriculum known as the Blueprint for Prescriber Education for Extended-Release and Long-Acting Opioid (ER/LA) Analgesics. To provide a comprehensive educational program, our curriculum covers all aspects of this blueprint and more.
Research Analysis Coordination
For the Center for Substance Abuse Treatment (CSAT) Addressing Opioid-Related Misuse and Overdose contract, Bizzell builds on Substance Abuse and Mental Health Services Administration’s (SAMHSA) previous workforce competency efforts for pain management and addiction professionals by developing and implementing multifaceted initiatives and strategies to address opioid use disorder and related conditions. Specifically, these initiatives and strategies focus on utilizing research, assessment, education, and training to:
Build infrastructure that ensures the availability of qualified healthcare professionals capable of meeting the challenges of opioid use disorder and other emerging issues
Disseminate new medical, clinical, and technological interventions to address substance misuse
Our clients drive real-world change. We accelerate it. We meet complex challenges with comprehensive, innovative solutions. We are prepared to meet your greatest challenges and develop strategies that meet your impact goals.